You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Btk

Showing 1 - 25 of 459
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)

Not yet recruiting
  • CLL/SLL
  • lisaftoclax +BTK inhibitor
  • BTK inhibitor
  • (no location specified)
Oct 26, 2023

The Cre8™ BTK Post Market Clinical Follow-up Study

Not yet recruiting
  • Peripheral Arterial Disease
  • Cre8™ BTK
  • Abano Terme, Padova, Italy
  • +1 more
Nov 8, 2022

B-cell Non Hodgkin Lymphoma Trial in Xuzhou (regimen with BTK inhibitor +Anti-CD19 CAR T cells)

Recruiting
  • B-cell Non Hodgkin Lymphoma
  • regimen with BTK inhibitor +Anti-CD19 CAR T cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

Atrial Fibrillation Trial in Caen (Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®))

Not yet recruiting
  • Atrial Fibrillation
  • Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®)
  • Caen, Normandie, France
    Caen University Hospital, Department of Pharmacology
Sep 6, 2023

BTK Inhibitors-related AF Treated by Catheter Ablation

Not yet recruiting
  • BTKi-induced Atrial Fibrillation
  • +2 more
  • Atrial fibrillation catheter ablation in a population of BTKi-induced atrial fibrillation
  • Caen, Normandy, France
    Caen University Hospital
Nov 10, 2023

Newly Diagnosed Mantle Cell Lymphoma Trial in Zhengzhou (Rituximab)

Recruiting
  • Newly Diagnosed Mantle Cell Lymphoma
  • Zhengzhou, Henan, China
    Department of Oncology, The First Affiliated Hospital of Zhengzh
Aug 17, 2022

Mantle Cell Lymphoma, Mantle Cell Lymphoma Refractory Trial (Glofitamab, Pirtobrutinib, Obinutuzumab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Mantle Cell Lymphoma Refractory
  • (no location specified)
Apr 18, 2023

Peripheral Artery Disease, Arterial Disease of Legs, Atherosclerosis Trial in Singapore (ABLUMINUS DES drug eluting stent)

Recruiting
  • Peripheral Artery Disease
  • +2 more
  • ABLUMINUS DES drug eluting stent
  • Singapore, Singapore
    Sengkang General Hospital
Jun 6, 2022

Cardiac Arrhythmias in Subjects Treated With BTK Inhibitors

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 16, 2023

    Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
    • Waldenstrom Macroglobulinemia (WM)
    • Shingrix vaccine
    • Rochester, New York
      University of Rochester
    Jan 9, 2023

    Critical Limb Ischemia (CLI) Trial in Australia, Taiwan, United States (Esprit BTK Device)

    Recruiting
    • Critical Limb Ischemia (CLI)
    • Esprit BTK Device
    • South Dartmouth, Massachusetts
    • +4 more
    Apr 26, 2022

    Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities Trial (SELUTION SLR™ DEB

    Not yet recruiting
    • Peripheral Arterial Disease
    • Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
    • SELUTION SLR™ DEB 014
    • Plain (Uncoated) Balloon Angioplasty (PTA)
    • (no location specified)
    Apr 5, 2022

    Primary CNS Lymphoma Trial in Zhengzhou (the dose-escalation phase)

    Recruiting
    • Primary Central Nervous System Lymphoma
    • the dose-escalation phase
    • Zhengzhou, Henan, China
      Oncology Department of The First Affiliated Hospital of Zhengzho
    May 30, 2022

    BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND)

    Withdrawn
    • COVID-19
      • Baltimore, Maryland
      • +2 more
      Feb 23, 2022

      Peripheral Arterial Disease Trial in Miami Beach, Davenport (Auryon Laser System)

      Recruiting
      • Peripheral Arterial Disease
      • Auryon Laser System
      • Miami Beach, Florida
      • +1 more
      Apr 4, 2022

      Peripheral Arterial Disease Trial in Germany, Netherlands, United Kingdom (StellarexTM 0.014" Over-The-Wire Drug-coated

      Active, not recruiting
      • Peripheral Arterial Disease
      • StellarexTM 0.014" Over-The-Wire Drug-coated Angioplasty Balloon
      • Frankfurt, Germany
      • +8 more
      Jul 25, 2022

      Critical Limb Ischemia Trial in Saint Helena, Leipzig (MOTIV Sirolimus-Eluting Bioresorbable Scaffold, Percutaneous Transluminal

      Recruiting
      • Critical Limb Ischemia
      • MOTIV Sirolimus-Eluting Bioresorbable Scaffold
      • Percutaneous Transluminal Angioplasty (PTA) Device
      • Saint Helena, California
      • +1 more
      Oct 19, 2022

      Peripheral Artery Disease Trial in Beijing (DEB catheter)

      Recruiting
      • Peripheral Artery Disease
      • DEB catheter
      • Beijing, Beijing, China
        Chui Yang Liu Hospital affiliated to Tsinghua University
      Aug 17, 2022

      PAD, Vascular Calcification Trial in Austria, Germany (Peripheral Orbital Atherectomy System, 014 Drug Coated Balloon)

      Completed
      Has Results
      • PAD
      • Vascular Calcification
      • Peripheral Orbital Atherectomy System
      • 014 Drug Coated Balloon
      • Graz, Austria
      • +6 more
      Feb 14, 2022

      Waldenstrom Macroglobulinemia Trial (Zanubrutinib)

      Not yet recruiting
      • Waldenstrom Macroglobulinemia
      • (no location specified)
      Nov 28, 2022

      Hepatitis, Safety and Tolerability Trial run by the NHLBI (HEPLISAV-B)

      Completed
      Has Results
      • Hepatitis
      • Safety and Tolerability
      • HEPLISAV-B
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 13, 2022

      Neuromyelitis Optica Trial in Beijing (zanubrutinib)

      Recruiting
      • Neuromyelitis Optica
      • Beijing, Beijing, China
        XuanWu Hospital
      May 15, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Duarte (procedure, biological, drug)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Biospecimen Collection
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Jan 30, 2023

      Diffuse Large B Cell Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Wuhan (BTK inhibitor+ Fludarabine +

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • +4 more
      • BTK inhibitor+ Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
      • Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
      • Wuhan, Hubei, China
        Union Hospital, Huazhong University of Science and Technology
      Oct 13, 2021

      Mantle Cell Lymphoma Trial in Beijing (DTRMWXHS-12)

      Active, not recruiting
      • Mantle Cell Lymphoma
      • Beijing, China
        Peking University Cancer Hospital
      Aug 18, 2021